These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15307145)

  • 21. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R; Mohapel P; Brundin P; Paul G
    Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease.
    Anstrom KK; Schallert T; Woodlee MT; Shattuck A; Roberts DC
    Behav Brain Res; 2007 May; 179(2):183-91. PubMed ID: 17374405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Gu S; Huang H; Bi J; Yao Y; Wen T
    Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.
    Cheng B; Yang X; An L; Gao B; Liu X; Liu S
    Brain Res; 2009 Aug; 1286():25-31. PubMed ID: 19559687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of the subthalamic nucleus upon the damage to the dopamine system following lesions of globus pallidus in rats.
    Wright AK; Arbuthnott GW
    Eur J Neurosci; 2007 Aug; 26(3):642-8. PubMed ID: 17634067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-parkinsonian rats.
    Poulton NP; Muir GD
    Exp Neurol; 2005 May; 193(1):181-97. PubMed ID: 15817277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.
    Mu X; He G; Cheng Y; Li X; Xu B; Du G
    Pharmacol Biochem Behav; 2009 Jun; 92(4):642-8. PubMed ID: 19327378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
    Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism.
    Brown AR; Hu B; Antle MC; Teskey GC
    Exp Neurol; 2009 Nov; 220(1):162-70. PubMed ID: 19703443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pallidotomy on motor symptoms in an animal model of Parkinson's disease.
    Henderson J; Doherty K; Allbutt H; Billing R
    Behav Brain Res; 2006 Apr; 169(1):29-38. PubMed ID: 16406102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model.
    Rauch F; Schwabe K; Krauss JK
    Behav Brain Res; 2010 Jun; 210(1):46-53. PubMed ID: 20138919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats.
    Fang X; Sugiyama K; Akamine S; Namba H
    Neurosci Res; 2006 Aug; 55(4):403-9. PubMed ID: 16730826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of microglial activation and degeneration of dopamine-containing neurons in a rat model of Parkinson disease induced by 6-hydroxydopamine.
    Henry V; Paillé V; Lelan F; Brachet P; Damier P
    J Neuropathol Exp Neurol; 2009 Oct; 68(10):1092-102. PubMed ID: 19918121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.